← SynDRA
RAMATROBAN
SynDRA canonical compound SYN0005587 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | TBXA2R |
| Mechanism of action | Prostanoid receptor antagonist |
| Indication | asthma | coronary artery disease (CAD) |
| Disease area | cardiology | pulmonary |
All known targets
- PTGDR2
- TBXA2R
- CCL2
- PTGDR
- Ptgdr2
Mechanisms of action (all sources)
- Prostanoid receptor antagonist
- PTGDR2 ANTAGONIST
- G protein-coupled receptor 44 antagonist
- TBXA2R ANTAGONIST
- Thromboxane A2 receptor antagonist
- TBXA2R INVERSE AGONIST
Drug classes
- Hematologic Agents
- Platelet Aggregation Inhibitors
Cross-references
Synonyms
- baynas
- Baynas
- BAY-U-3405
- EN-137774
- BAY u3405
- BAY-u 3405
- Bay u 3406
- UNII-P1ALI72U6C
- C21H21FN2O4S
- 3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid
- P1ALI72U6C
- 3-(4-Fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazole propanoic acid
- CHEMBL361812
- (+)-(3R)-3-(p-Fluorobenzenesulfonamido)-1,2,3,4-tetrahydrocarbazole-9-propionic acid
- NCGC00167519-01
- DSSTox_RID_81819
- Baynas (TN)
- Ramatroban (JAN/INN)
- [3H]ramatroban
- Bay u-3405
- (R)-3-(3-(4-fluorophenylsulfonamido)-3,4-dihydro-1H-carbazol-9(2H)-yl)propanoic acid
- 9H-Carbazole-9-propanoic acid, 3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-, (3R)-
- EN 137774
- (3R)-3-[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic Acid
- [3H]baynas
- CAS-116649-85-5
- Ramatroban [INN:BAN]
- [3H]Bay u 3405
- [3H]BAY u3405
- 3R-[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid
- (3R)-3-(((4-FLUOROPHENYL)SULFONYL)AMINO)-1,2,3,4-TETRAHYDRO-9H-CARBAZOLE-9-PROPANOIC ACID
- 9H-CARBAZOLE-9-PROPANOIC ACID, 3-(((4-FLUOROPHENYL)SULFONYL)AMINO)-1,2,3,4-TETRAHYDRO-, (3R)-
- MFCD00887606
- RAMATROBAN [MI]
- RAMATROBAN [INN]
- RAMATROBAN [JAN]
- RAMATROBAN [MART.]
- 9H-Carbazole-9-propanoic acid, 3-(((4-fluorophenyl)sulfonyl)amino)-1,2,3,4-tetrahydro-, (R)-
Look up RAMATROBAN in the interactive SynDRA portal →